시장보고서

상품코드

1606433

크로노테라피 서비스 시장 : 제품 유형별, 치료 영역별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Chronotherapy Services Market, By Product Type, By Therapeutic Area, By End-user, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

크로노테라피 서비스 시장 규모는 2023년에 8억 7,090만 달러에 달하며, 2024-2032년 CAGR 4.50%로 확대

크로노테라피 서비스 시장 - 시장 역학

크로노테라피는 기분 장애 치료를 최적화하는 것으로, 정신건강을 지원합니다.

크로노테라피는 정신건강 치료, 특히 우울증, 불안장애, 계절성 정서장애(SAD)와 같은 기분장애 치료에서 인기를 끌고 있습니다. 이러한 성장의 주요 원동력은 일주기 리듬이 정신건강에 미치는 중요한 역할에 대한 이해 증가에 기인합니다. 신체의 자연적 수면 및 각성 주기의 교란이 기분 불균형으로 이어지는 경우가 증가하고 있으며, 크로노테라피는 생체 시계에 맞추어 치료 시기를 조정함으로써 이를 해결할 수 있습니다. 빛 치료의 수면 최적화 기술과 약물 투여 타이밍의 발전은 기분 장애 관리에 대한 효과를 더욱 지원하고 있습니다. 또한 개인화된 환자 중심 치료 모델의 채택이 증가하고 있는 것도 중요한 요인으로 작용하고 있습니다.

또 다른 연구 결과에 따르면 크로노테라피는 치료 시기를 최적화함으로써 약물의 부작용을 줄이고 치료 효과를 높일 수 있다는 연구 결과도 있습니다. 미국 국립정신건강연구소(NIMH)는 일주기 리듬의 교란이 정신질환과 밀접한 관련이 있음을 강조하며 이 시장의 잠재력을 더욱 입증하고 있습니다. 캘리포니아대학교 버클리 캠퍼스와 같은 대학에서는 기분 조절에 있으며, 일주기 생물학의 역할에 대한 연구를 진행하고 있으며, 이는 크로노테라피를 효과적으로 시행할 수 있는 방법에 대한 귀중한 인사이트을 제공합니다.

크로노테라피 서비스 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 4.50%의 연평균 복합 성장률(CAGR)로 성장할 것으로 추정됩니다.

제품 유형별로는 크로노테라피 의약품이 22023년 가장 높은 시장 점유율을 차지했습니다.

치료 영역별로는 2023년 종양학이 주요 유형으로 부상할 것으로 예상됩니다.

최종사용자별로는 2023년 병원 및 클리닉이 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출 1위

크로노테라피 서비스 시장 - 세분화 분석 :

크로노테라피 서비스 세계 시장은 제품 유형, 치료 영역, 최종사용자 및 지역을 기준으로 세분화됩니다.

시장은 제품 유형에 따라 크로노테라피 시스템과 크로노테라피 의약품의 두 가지로 분류됩니다. 크로노테라피 서비스 시장에서 크로노테라피 의약품 분야가 가장 두드러지고 중요합니다. 이는 주로 치료 효과를 높이기 위해 약물전달의 타이밍이 중요하다는 인식이 확산되고 있기 때문입니다. 크로노테라피 의약품은 신체의 자연적인 일주기 리듬에 맞추어 작용하도록 특별히 설계되어 천식, 고혈압, 암 등의 치료 결과를 개선합니다. 만성질환의 유병률 증가와 맞춤형 의료에 대한 수요는 크로노테라피 의약품의 채택을 촉진하고 시장을 장악하고 있습니다. 또한 약물 제제 및 약물전달 시스템의 발전은 그 존재감을 더욱 높이고 있습니다.

시장은 치료 분야별로 종양학, 신경학, 심혈관 질환, 호흡기 질환, 기타 등 5개 카테고리로 분류됩니다. 크로노테라피 서비스 시장에서 암 분야가 가장 두드러지고 중요합니다. 암 치료는 약효를 최적화하고 부작용을 최소화하기 위해 정확한 타이밍이 필요한 경우가 많은데, 크로노테라피가 특히 유용합니다. 화학요법의 타이밍을 신체의 일주기 리듬에 맞추면 약물의 효과를 높이고, 환자의 예후를 개선하며, 독성을 감소시킬 수 있습니다. 전 세계 암 발병률 증가와 크로노테라피 연구의 발전으로 종양학은 주요 치료 분야가 되어 크로노테라피 서비스 시장 성장의 대부분을 주도하고 있습니다. 또한 환자의 순응도와 치료 결과를 개선할 수 있는 잠재력이 그 이점을 더욱 강화하고 있습니다.

크로노테라피 서비스 시장 - 지역적 인사이트

북미의 크로노테라피 서비스 시장은 특히 수면장애, 우울증, 고혈압과 같은 만성질환 관리에서 맞춤형 의료에 대한 수요가 증가하고 있는 것이 특징입니다. 생체리듬과 건강에 미치는 영향에 대한 인식이 높아짐에 따라 크로노테라피는 임상과 웰니스 분야 모두에서 지지를 얻고 있습니다. 미국은 의료 기술의 발전, 고령화, 높은 의료비 지출에 힘입어 시장을 선도하고 있습니다. 캐나다도 특히 연구 및 학술 분야에서 성장세를 보이고 있습니다. 이 지역의 주요 업체들은 웨어러블 기기, 디지털 플랫폼 등 치료 시기를 최적화하기 위한 혁신적인 솔루션 개발에 주력하고 있습니다. 정부 규제, 보험 적용 범위, 의료 인프라는 시장 역학 형성에 중요한 역할을 합니다. 그러나 임상 검증과 환자 도입의 필요성 등 과제는 여전히 남아있습니다.

크로노테라피 서비스 시장 - 경쟁 구도:

크로노테라피 서비스 시장 경쟁 구도는 대형 제약사, 바이오테크 전문 기업, 일주기 리듬에 기반한 치료에 집중하는 스타트업이 혼재되어 있습니다. 존슨앤드존슨, 화이자, 노바티스 등 대형 제약사들은 크로노바이오로지 연구에 투자하여 방출 조절 약물이나 크로노테라피에 특화된 약물전달 시스템 등 특정 시간대에 최적화된 치료제를 개발하고 있습니다. 서카디안 테라퓨틱스(Circadian Therapeutics)와 같은 소규모의 혁신적인 기업은 개인 맞춤형 크로노테라피 모델을 개발하여 맞춤형 치료 솔루션을 제공합니다. 이 시장은 또한 암, 정신질환, 수면 관련 질환과 같은 증상에 대한 크로노바이오로지의 새로운 적용을 모색하는 의료 서비스 프로바이더, 대학 및 연구기관들의 공동 연구로 지원되고 있습니다. 경쟁 전략에는 약물 처방의 기술적 진보, 생체리듬을 모니터링하기 위한 웨어러블 기기 사용, 환자 예후를 개선하기 위한 정밀의료 개발 등이 포함됩니다. 생체시계와 동기화된 치료의 이점에 대한 인식이 높아짐에 따라 향후 경쟁이 더욱 치열해질 것으로 예상됩니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 크로노테라피 서비스업계

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 개요
- Johnson &Johnson
- Novartis
- Pfizer
- Merck &Co.
- Sanofi
- Roche
- GlaxoSmithKline
- AbbVie
- Bayer
- Eli Lilly and Company
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Gilead Sciences
- Teva Pharmaceutical Industries
- Medtronic
- Zogenix
- Circadian Therapeutics

제12장 애널리스트의 전방위적 전망

KSA 24.12.24

REPORT HIGHLIGHT

Chronotherapy Services Market size was valued at USD 870.90 million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

The chronotherapy services market refers to the industry focused on aligning medical treatments with an individual's natural biological rhythms, such as the circadian cycle. This approach involves timing interventions like medication administration, lifestyle changes, or therapy sessions based on optimal periods during the day when the body is most receptive to treatment. Chronotherapy aims to enhance the efficacy of treatments, minimize side effects, and improve patient outcomes. It is especially relevant in areas such as sleep disorders, cardiovascular health, cancer treatment, and mental health. As the understanding of the circadian rhythm grows, more healthcare providers are adopting chronotherapy to optimize care. The market is expected to grow as personalized medicine and precision therapies continue to advance. Key drivers include increasing awareness of chronobiology and innovations in drug delivery systems.

Chronotherapy Services Market- Market Dynamics

Chronotherapy aids mental health by optimizing treatment for mood disorders.

Chronotherapy is gaining traction in mental health treatment, particularly for mood disorders like depression, anxiety, and seasonal affective disorder (SAD). The primary driver for this growth is the growing understanding of the significant role circadian rhythms play in mental health. Disruptions in the body's natural sleep-wake cycles are increasingly linked to mood imbalances, which chronotherapy can address by aligning treatment timing with the body's biological clock. Advancements in light therapy sleep optimization techniques and drug administration timing further support its efficacy in mood disorder management. Furthermore, the rising adoption of personalized, patient-centric care models is a key factor.

Research is also showing that chronotherapy can reduce medication side effects and enhance therapeutic outcomes by optimizing when treatments are administered. The National Institute of Mental Health (NIMH) highlights that circadian rhythm disruptions are strongly associated with mental health disorders, further validating the market's potential. Universities, such as the University of California, Berkeley, are conducting studies on circadian biology's role in mood regulation, providing valuable insights into how chronotherapy can be implemented effectively.

Chronotherapy Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)

Based on Product Type segmentation, Chronotherapy Drugs was predicted to show maximum market share in the year 2023

Based on Therapeutic Area segmentation, Oncology was the leading type in 2023

Based on End-user segmentation, Hospitals & Clinics was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Chronotherapy Services Market- Segmentation Analysis:

The Global Chronotherapy Services Market is segmented based on Product Type, Therapeutic Area, End-user, and Region.

The market is divided into two categories based on Product Type: Chronotherapy System and Chronotherapy Drugs. In the Chronotherapy Services Market, the Chronotherapy Drugs segment is the most prominent and significant. This is primarily due to the increasing recognition of the importance of timing in drug delivery to enhance therapeutic efficacy. Chronotherapy drugs are specifically designed to work in sync with the body's natural circadian rhythms, improving treatment outcomes for conditions like asthma, hypertension, and cancer. The growing prevalence of chronic diseases and the demand for personalized medicine have driven the adoption of chronotherapy drugs, making them the dominant force in the market. Additionally, advancements in drug formulation and delivery systems have further bolstered their prominence.

The market is divided into five categories based on Therapeutic areas: Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, and Others. In the Chronotherapy Services Market, the Oncology segment is the most prominent and significant. Cancer treatments often require precise timing to optimize drug efficacy and minimize side effects, making chronotherapy particularly valuable. Timing chemotherapy treatments to align with the body's circadian rhythms can enhance the effectiveness of drugs, improve patient outcomes, and reduce toxicity. With increasing cancer incidence globally and advancements in chronotherapy research, oncology has become the dominant therapeutic area, driving much of the growth in the chronotherapy services market. Further, the potential for improved patient compliance and treatment results further strengthens its prominence.

Chronotherapy Services Market- Geographical Insights

The North American regional landscape for the Chronotherapy Services market is characterized by a growing demand for personalized healthcare, especially in managing chronic conditions such as sleep disorders, depression, and hypertension. As the awareness of circadian rhythms and their impact on health increases, chronotherapy is gaining traction in both clinical and wellness settings. The U.S. leads the market, driven by advancements in medical technology, an aging population, and high healthcare expenditure. Canada is also showing growth, particularly in research and academic sectors. Key players in the region are focusing on developing innovative solutions, such as wearable devices and digital platforms, to optimize treatment timing. Government regulations, insurance coverage, and healthcare infrastructure play significant roles in shaping market dynamics. However, challenges like the need for clinical validation and patient adoption remain.

Chronotherapy Services Market- Competitive Landscape:

The competitive landscape of the chronotherapy services market is shaped by a mix of pharmaceutical giants, specialized biotechnology firms, and emerging players focusing on circadian rhythm-based therapies. Major pharmaceutical companies like Johnson & Johnson, Pfizer, and Novartis are investing in chronobiology research and developing treatments optimized for specific times of day, such as controlled-release medications or chronotherapy-focused drug delivery systems. Smaller, innovative companies like Circadian Therapeutics are advancing personalized chronotherapy models and offering tailored treatment solutions. The market is also supported by collaborations between healthcare providers, universities, and research institutes to explore new applications of chronobiology in conditions like cancer, mental health disorders, and sleep-related diseases. Competitive strategies include technological advancements in drug formulation, the use of wearable devices to monitor circadian rhythms, and the development of precision medicine to enhance patient outcomes. Growing awareness about the benefits of synchronizing treatment with biological clocks is expected to drive future competition.

Recent Developments:

In September 2023, Medtronic launched a pilot program to explore the benefits of chronotherapy for heart disease patients. Preliminary data suggests that aligning drug delivery with circadian rhythms could improve blood pressure management more effectively than traditional treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONOTHERAPY SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Johnson & Johnson
Novartis
Pfizer
Merck & Co.
Sanofi
Roche
GlaxoSmithKline
AbbVie
Bayer
Eli Lilly and Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical Industries
Medtronic
Zogenix
Circadian Therapeutics

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Chronotherapy System
Chronotherapy Drugs

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Oncology
Neurology
Cardiovascular Diseases
Respiratory Diseases
Others

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Homecare Settings
Others

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Chronotherapy Services Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Chronotherapy Services Market Snippet by Product Type
- 2.1.2. Chronotherapy Services Market Snippet by Therapeutic Area
- 2.1.3. Chronotherapy Services Market Snippet by End-user
- 2.1.4. Chronotherapy Services Market Snippet by Country
- 2.1.5. Chronotherapy Services Market Snippet by Region
2.2. Competitive Insights

3. Chronotherapy Services Key Market Trends

3.1. Chronotherapy Services Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Chronotherapy Services Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Chronotherapy Services Market Opportunities
3.4. Chronotherapy Services Market Future Trends

4. Chronotherapy Services Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Chronotherapy Services Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Chronotherapy Services Market Landscape

6.1. Chronotherapy Services Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Chronotherapy Services Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023&2032 (%)
- 7.1.2. Chronotherapy System
- 7.1.3. Chronotherapy Drugs

8. Chronotherapy Services Market - By Therapeutic Area

8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapeutic Area, 2023&2032 (%)
- 8.1.2. Oncology
- 8.1.3. Neurology
- 8.1.4. Cardiovascular Diseases
- 8.1.5. Respiratory Diseases
- 8.1.6. Others

9. Chronotherapy Services Market - By End-user

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-user, 2023&2032 (%)
- 9.1.2. Hospitals & Clinics
- 9.1.3. Homecare Settings
- 9.1.4. Others

10. Chronotherapy Services Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023&2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Chronotherapy Services Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.7. The U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Chronotherapy Services Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Chronotherapy Services Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Chronotherapy Services Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Chronotherapy Services Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Chronotherapy Services Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Johnson & Johnson
- 11.2.2. Novartis
- 11.2.3. Pfizer
- 11.2.4. Merck & Co.
- 11.2.5. Sanofi
- 11.2.6. Roche
- 11.2.7. GlaxoSmithKline
- 11.2.8. AbbVie
- 11.2.9. Bayer
- 11.2.10. Eli Lilly and Company
- 11.2.11. Amgen
- 11.2.12. AstraZeneca
- 11.2.13. Bristol-Myers Squibb
- 11.2.14. Gilead Sciences
- 11.2.15. Teva Pharmaceutical Industries
- 11.2.16. Medtronic
- 11.2.17. Zogenix
- 11.2.18. Circadian Therapeutics

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us